One specific clinical group sees huge surge in GLP-1 prescriptions

Wait 5 sec.

Skip to contentSwipe for next articleIndependent Bulletin homepageDownload our appAllNewsSportCultureLifestyleWant to bookmark your favourite articles and stories to read or reference later? Start your Independent Membership today.Join todayAlready a member? Log inJulia MustoThursday 01 October 2026 23:13 BSTJB Pritzker reveals why he decided to start taking GLP-1 drugsGLP-1 prescriptions for new American mothers increased 24-fold between 2018 and 2025, according to a University of Southern California study.The percentage of postpartum women receiving GLP-1 prescriptions grew from 0.8 percent in 2018 to 1.9 percent by early 2025, mostly initiated three to six months after delivery.The sharpest increases in prescriptions occurred among mothers diagnosed with type 2 diabetes, gestational diabetes, or pre-pregnancy obesity.Researchers warn that safety data regarding GLP-1 medication exposure during breastfeeding remains extremely limited.Medical experts currently recommend against taking GLP-1 drugs while nursing due to uncertain risks to infant growth and development.In fullMore new US moms are taking GLP-1 drugsMore bulletinsThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in